News

The Wall Street Journal: FDA approves Biogen’s Alzheimer’s drug, the first to slow the disease

0

The first drug promising to slow the memory-robbing march of Alzheimer’s disease was approved by U.S. health regulators, a watershed after years of research and billions of dollars in investment.

: One Medical to buy Iora Health for $2.1 billion

Previous article

Key Words: ‘Resist the temptation’ to short AMC Entertainment, other meme stocks ‘because these prices can go to unimaginable highs,’ says Interactive Brokers founder

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News